Correvio Pharma Corp. Operating Expenses
Correvio Pharma Corp. reported Operating Expenses of $50.26 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2020-04-30
| Period end | Operating Expenses 12 month |
|---|---|
| 2019-12-31 | $50.26M 20-F · filed 2020-04-30 |
| 2018-12-31 | $46.72M 20-F · filed 2020-04-30 |
| 2017-12-31 | $40.21M 20-F · filed 2020-04-30 |
| 2016-12-31 | $33.50M 20-F · filed 2018-04-30 |
| 2015-12-31 | $36.40M 20-F · filed 2018-04-30 |
| 2014-12-31 | $36.60M 40-F · filed 2016-03-29 |
| 2013-12-31 | $20.27M 40-F · filed 2015-03-27 |
| 2012-12-31 | $26.75M 40-F/A · filed 2014-04-30 |
| 2011-12-31 | $27.96M 20-F/A · filed 2013-04-18 |
| 2010-12-31 | $29.39M 20-F/A · filed 2013-04-18 |